Lanifibranor and NASH resolution

Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):832. doi: 10.1038/s41575-021-00544-z.
No abstract available

Publication types

  • Comment

MeSH terms

  • Benzothiazoles
  • Humans
  • Non-alcoholic Fatty Liver Disease* / diagnosis
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Sulfonamides

Substances

  • Benzothiazoles
  • Sulfonamides
  • lanifibranor